The Frank-Starling mechanism is depressed in hypertrophic and dilated cardiomyopathies via different mechanisms involving altered thin filament cooperative activation and titin isoform switching.
The heart has an intrinsic ability to increase systolic force in response to a rise in ventricular filling (the Frank-Starling law of the heart). It is widely accepted that the length dependence of myocardial activation underlies the Frank-Starling law of the heart. Recent advances in muscle physiology have enabled the identification of the factors involved in length-dependent activation, viz., titin (connectin)-based interfilament lattice spacing reduction and thin filament "on-off" regulation, with the former triggering length-dependent activation and the latter determining the number of myosin molecules recruited to thin filaments. Patients with a failing heart have demonstrated reduced exercise tolerance at least in part via depression of the Frank-Starling mechanism. Recent studies revealed that various mutations occur in the thin filament regulatory proteins, such as troponin, in the ventricular muscle of failing hearts, which consequently alter the Frank-Starling mechanism. In this article, we review the molecular mechanisms of length-dependent activation, and the influence of troponin mutations on the phenomenon.
Kobirumaki-Shimozawa et al. (Wed,) conducted a review in Heart failure, Cardiomyopathy. Thin filament regulation and titin was evaluated. The Frank-Starling mechanism is depressed in hypertrophic and dilated cardiomyopathies via different mechanisms involving altered thin filament cooperative activation and titin isoform switching.